Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H15NO2.ClH |
Molecular Weight | 217.693 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.COC1=C(OC)C=C(CCN)C=C1
InChI
InChIKey=WIOOTMZLCZPTDW-UHFFFAOYSA-N
InChI=1S/C10H15NO2.ClH/c1-12-9-4-3-8(5-6-11)7-10(9)13-2;/h3-4,7H,5-6,11H2,1-2H3;1H
Homoveratrylamine (3,4-dimethoxyphenethylamine, DMPEA) is an analog of the major neurotransmitter dopamine where 3- and 4- position hydroxyl groups are replaced with methoxy groups. DMPEA is a metabolite of dopamine and is reported to be produced at elevated levels in patients with schizophrenia and Parkinson's disease. DMPEA inhibited monoamine oxidase and demonstrated no peripheral and central antidopaminergic activity in vivo.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2095205 Sources: https://www.ncbi.nlm.nih.gov/pubmed/14459693 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
3,4-dimethoxyphenethylamine (DMPEA) and schizophrenia. | 1979 Feb |
|
Fine structural specificity differences of trimethoprim allergenic determinants. | 1996 Oct |
|
Kinetics study of amine cleavage reactions of various resin-bound thiophenol esters from marshall linker. | 2002 Jul-Aug |
|
Inhibition of brain mitochondrial respiration by dopamine and its metabolites: implications for Parkinson's disease and catecholamine-associated diseases. | 2004 Nov |
|
[Syntheses and ring-closures of difunctional tetrahydroisoquinolines]. | 2006 |
|
Contribution of aldehyde oxidizing enzymes on the metabolism of 3,4-dimethoxy-2-phenylethylamine to 3,4-dimethoxyphenylacetic acid by guinea pig liver slices. | 2006 |
|
The structure of ammonium pyrazolates in the solid state. | 2006 Dec |
|
Evaluation of dimethoxydop-NU as a novel anti-tumor agent. | 2007 Dec |
|
4-[2-(3,4-Dimethoxy-phenethyl-amino)prop-oxy]-2-methoxy-benzamide. | 2008 May 24 |
|
Self-assembly of 3,5-bis(ethoxycarbonyl)pyrazolate anions and ammonium cations of beta-phenylethylamine or homoveratrylamine into hetero-double-stranded helical structures. | 2009 Aug 21 |
|
Enhancement of 5-aminopenta-2,4-dienals electrophilicity via activation by O,N-bistrifluoroacetylation. application to an N-acyl Pictet-Spengler reaction. | 2009 Dec 18 |
|
2-(4-Chloro-phen-yl)-5-(3,4-dimethoxy-pheneth-yl)-6,7-dihydro-pyrazolo[1,5-a]pyrazin-4(5H)-one. | 2009 Jun 6 |
|
Structure-activity relationships of anthraquinone derivatives derived from bromaminic acid as inhibitors of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases). | 2009 Mar |
|
An overview of Indian research in schizophrenia. | 2010 Jan |
|
(E)-N-(3,4-Dimethoxy-pheneth-yl)-3-methoxy-but-2-enamide. | 2010 Jan 23 |
|
Selective electrochemical discrimination between dopamine and phenethylamine-derived psychotropic drugs using electrodes modified with an acyclic receptor containing two terminal 3-alkoxy-5-nitroindazole rings. | 2010 Jun |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27614
In vivo experiments with DMPEA were performed on mice. Compound was administered intraperitoneally at doses 25-200 mg/kg.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14459693
Brain mitochondria, containing monoamine oxidase, were prepared from Wistar female rats. Monoamine oxidase activity was determined in the presence and absence of the DMPEA by manometric technique. The main compartment of Warburg flasks contained 0.8 ml of a 0.1 M buffered solution of the homoveratrylamine, 1 ml of mitochondrial suspension (representing 500 mg wet weight of original brain tissue), and sufficient 0.01 M phosphate buffer (pH 7.4) to make a total volume of 2.7 ml. All aliquots for a given run were taken from the same mitochondrial preparation. The side arm of each flask contained 0.3 ml of 0.1 M tyramine or tryptamine hydrochloride. After the flasks were allowed to equilibrate for 15 min at 37°, the manometer valves were closed and the side arm contents of each were tipped in. Manometers were set at 150 mm, and readings were taken at 15-min intervals for 90 min. Values for the 90-min reaction period were obtained for each flask and were multiplied by the respective flask constants after adjusting for changes in the thermobarometer. The total microliters of oxygen uptake for each flask was thus obtained.
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
14141
Created by
admin on Sat Dec 16 02:55:24 GMT 2023 , Edited by admin on Sat Dec 16 02:55:24 GMT 2023
|
PRIMARY | |||
|
141621
Created by
admin on Sat Dec 16 02:55:24 GMT 2023 , Edited by admin on Sat Dec 16 02:55:24 GMT 2023
|
PRIMARY | |||
|
71555
Created by
admin on Sat Dec 16 02:55:24 GMT 2023 , Edited by admin on Sat Dec 16 02:55:24 GMT 2023
|
PRIMARY | |||
|
635-85-8
Created by
admin on Sat Dec 16 02:55:24 GMT 2023 , Edited by admin on Sat Dec 16 02:55:24 GMT 2023
|
PRIMARY | |||
|
TTV20379WY
Created by
admin on Sat Dec 16 02:55:24 GMT 2023 , Edited by admin on Sat Dec 16 02:55:24 GMT 2023
|
PRIMARY | |||
|
DTXSID00212904
Created by
admin on Sat Dec 16 02:55:24 GMT 2023 , Edited by admin on Sat Dec 16 02:55:24 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD